Mainz Biomed NV announces the live launch of Mainz Biomed?s flagship product, ColoAlert® a highly effective and user-friendly at-home detection test for colorectal cancer (CRC) - with strategic partner Bioclinica, a national leader in the Romanian healthcare sector. This partnership signifies a pivotal step towards enhancing healthcare outcomes in the country through advanced diagnostics. CRC incidence rates in Romania are among the highest in Europe.

With no national screening program in place, population data from Romania underscores the urgency to have diagnostic tests publicly available in the country to enhance CRC screening practices. With 1.6 million individuals aged 40 to 49 years, 6.1 million aged 50 to 74 years, and 1.5 million aged over 75 years, the potential market for ColoAlert® is substantial, reaching 9.2 million tests per year. The collaboration with Bioclinica adds significant value to Mainz Biomed's mission.

Leveraging the renowned expertise and extensive network of Bioclinica, ColoAlert® will immediately become available to a large portion of the Romanian population. Bioclinica, a trusted supplier of healthcare products with over 25 years of experience in medical diagnostics, operates 15 associated laboratories and 146 collection points across Romania. Mainz Biomed and Bioclinica will collaborate on co-marketing activities to ensure the successful commercial launch of ColoAlert® across the country.